Why this ASX All Ords healthcare share is defying the market weakness and zooming higher

Australian Clinical Labs has made a bold takeover approach for its larger rival.

| More on:
A telehealth doctor at her desk.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Australian Clinical Labs has made a takeover offer for Healius 
  • It is a fellow healthcare company that is twice its size
  • Australian Clinical Labs believes the value will be unlocked from merging their operations

The Australian Clinical Labs Ltd (ASX: ACL) share price is having a solid start to the week.

In morning trade, the ASX All Ords healthcare share is up 3% to $3.73.

Why is the ASX All Ords healthcare share rising?

The catalyst for this has been news that the company has launched a bold takeover approach for larger rival Healius Ltd (ASX: HLS).

According to the release, Australian Clinical Labs has made a nil-premium all-scrip off-market takeover offer of 0.74 shares for every Healius share.

While this may seem like an odd takeover proposal from the ASX All Ords healthcare share, there is method to its madness.

Australian Clinical Labs believes the real value of the proposal will come when the two companies merge.

It believes the merged entity would deliver pro forma earnings before interest and tax (EBIT) of $361 million in FY 2023. This includes cost synergies and operational improvement benefits.

Based on its forecast earnings and belief that it could trade at the current blended forward EV/EBIT multiple of 17.5x, it estimates that it could deliver a value uplift of approximately $2.1 billion. It notes that this equates to a 90% increase in the value per Healius share implied by the offer consideration.

Another positive is that Australian Clinical Labs believes the merged group would be a candidate for ASX 100 inclusion in time.

What's next?

As things stand, Healius has told its shareholders that it is looking at the offer. In the meantime, it has informed shareholders to take no action.

Management commented:

The Board of Healius advises shareholders to take no action in respect of ACL's takeover offer. The Board will evaluate the offer and ACL's bidder's statement and provide shareholders with a recommendation in due course.

Until then, there is no need for shareholders to take any action. Healius will keep its shareholders fully informed of any further developments.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Man jumps for joy in front of a background of a rising stocks graphic.
Healthcare Shares

Guess which ASX All Ords stock is jumping on big US news

This small cap is catching the eye on Thursday. But why?

Read more »

three excited doctors with hands in the air
Healthcare Shares

Two ASX healthcare shares that could be set to double

This broker has buy recommendations on these two shares. 

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Telix shares jump 7% on big US news

Let's see what is getting investors excited on Wednesday.

Read more »

An older gentleman leans over his partner's shoulder as she looks at a tablet device while seated at a table.
Healthcare Shares

Macquarie tips 28% upside for this ASX healthcare stock

The broker expects big things from this New Zealand retirement village developer and operator.

Read more »

Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital
Healthcare Shares

$10,000 invested in these ASX healthcare shares 5 years ago is now worth…

These healthcare stocks have brought big returns for investors 

Read more »

A man wearing a white coat and glasses is wide-mouthed in surprise.
Healthcare Shares

Guess which ASX 300 stock is crashing 55% today

What's going on with this stock? Let's see why investors are hitting the sell button.

Read more »

Woman serving customer in pharmacy.
Healthcare Shares

Up 132% in a year, are Sigma Healthcare shares still a good buy post the Chemist Warehouse merger?

After gaining 132% in 12 months, it too late to buy Sigma Healthcare shares today?

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Share Market News

Is it too late to buy Pro Medicus shares?

Pro Medicus shares have risen 550% over 3 years. Have you missed the boat? Three experts weigh in.

Read more »